Japanese Biotech Stock News

Token (TSE:1766) has posted its Q3 2026 numbers with total revenue of ¥95,611 million and basic EPS of ¥300.96, putting the spotlight firmly on how its top and bottom line are holding up through the year. Over recent quarters the company has seen revenue move from ¥89,974 million in Q2 2025 to ¥92,160 million in Q3 2025 and then to ¥95,611 million in Q3 2026, while basic EPS shifted from ¥249.48 to ¥340.46 and now ¥300.96, giving investors a clear read on how earnings are tracking alongside...

Kumiai Chemical Industry (TSE:4996) has opened fiscal 2026 with Q1 revenue of ¥46,707 million and basic EPS of ¥32.74, setting a fresh reference point after a volatile run of quarterly earnings. The company has seen revenue move from ¥43,381 million in Q1 2025 to ¥46,707 million in Q1 2026, while basic EPS shifted from ¥33.25 to ¥32.74 over the same periods. This gives investors a clean snapshot of the top and bottom line as they weigh how a thinner 2.5% trailing net margin and that prior...

Tri Chemical Laboratories (TSE:4369) has just wrapped up FY 2026 with fourth quarter revenue of ¥5.9b and basic EPS of ¥45.95, while its trailing twelve month figures sit at ¥23.9b of revenue and EPS of ¥169.71. Over the last six reported quarters, the company has seen revenue move between ¥5.1b and ¥6.6b and quarterly EPS range from ¥36.79 to ¥53.37, giving investors a clear view of how the top line and per share earnings have tracked into the latest full year. With a trailing net margin of...

Japan Eyewear Holdings (TSE:5889) has wrapped up FY 2026 with fourth quarter revenue of ¥5.2b and basic EPS of ¥46.91, alongside net income excluding extra items of ¥1.1b, setting the tone for how the full year is being read. Over the past six reported quarters, revenue has moved from ¥3.8b in FY 2025 Q3 to a range of ¥4.2b to ¥5.2b in FY 2026, while quarterly basic EPS has tracked between ¥31.08 and ¥65.18, giving investors a clear view of how the top line and EPS have paired up through the...

INTLOOP (TSE:9556) has reported Q2 2026 revenue of ¥9.7b and basic EPS of ¥9.29, with trailing twelve month EPS at ¥134.27 and net income of ¥1.26b, giving investors a clear read on recent profitability. The company has seen quarterly revenue move from ¥8.1b in Q2 2025 to ¥9.7b in Q2 2026, while basic EPS has ranged from ¥35.50 in Q2 2025 to ¥54.93 in Q4 2025 and ¥9.29 in the latest quarter. This sets up a story where margin resilience and earnings quality are front of mind for...

Why HOYA is on investors’ radar today HOYA (TSE:7741) has attracted attention after recent share price moves, with the stock up over the past 3 years and 5 years while posting mixed returns over the past week and month. See our latest analysis for HOYA. At a share price of ¥27,765, HOYA’s recent 7 day and 30 day share price returns of 2.61% and 2.44% declines contrast with a stronger 90 day share price return of 16.2% and a 1 year total shareholder return of 61.74%. This suggests longer term...

Liberaware (TSE:218A) has just posted its Q2 2026 scorecard, reporting revenue of ¥402.71 million and basic EPS of ¥4.75. The trailing twelve month figures show revenue of ¥1,488.82 million and basic EPS of ¥11.79. The company has recorded quarterly revenue between ¥307.57 million and ¥426.84 million over the past six reported periods, with EPS ranging from a loss of ¥57.07 to a gain of ¥72.58 before arriving at the latest ¥4.75 figure. This variability puts the focus on how sustainable...

RAKUMACHIInc (TSE:6037) has released its H1 2026 results, reporting revenue of ¥1,757 million and basic EPS of ¥36.43, alongside net income of ¥721 million, setting the tone for the latest earnings season update. The company’s revenue has moved from ¥1,529 million in H1 2025 to ¥1,630 million in H2 2025 and then to ¥1,757 million in H1 2026, while basic EPS has progressed from ¥24.66 to ¥31.54 and then ¥36.43 over the same halves, giving investors a clear view of how the top and bottom lines...

Ateam Holdings (TSE:3662) has just posted Q2 2026 results, with revenue of ¥5,790 million and a net loss of ¥66 million, translating to basic EPS of ¥3.55. The company has seen quarterly revenue move within a relatively tight band from ¥5,677 million in Q1 2025 to ¥6,429 million in Q3 2025. Basic EPS has swung from a profit of ¥25.21 in Q3 2025 to a modest ¥0.48 in Q4 2025 and a loss this quarter, keeping margins and earnings quality firmly in focus for investors. See our full analysis for...

Resona Holdings (TSE:8308) is reshaping its leadership, with the board approving promotions that place long serving insiders Shinichiro Isa and Nobuki Iwadate into expanded Deputy President roles. See our latest analysis for Resona Holdings. These leadership changes come as Resona Holdings trades at ¥1,747.5, with a 1 day share price return of 1.27%, a 30 day share price return decline of 19.08%, and a 1 year total shareholder return of 37.59%, suggesting longer term momentum remains stronger...

GIGABYTE recently announced a collaboration with Capcom to promote the upcoming Resident Evil Requiem game through a themed custom PC giveaway and bundled monitor-game offers, while Capcom’s board approved director changes and new management roles effective April 1, 2026. Together, the gaming hardware tie-in and leadership reshuffle highlight how Capcom is leaning on flagship IP while refining its internal business focus. We’ll now examine how the Resident Evil Requiem collaboration with...

Kyocera stock moves after recent performance Kyocera (TSE:6971) has attracted attention after a 1 day decline of 1.4%, following a 4.1% fall over the past week, even though the share price shows a 12.7% gain over the past 3 months. See our latest analysis for Kyocera. Short term momentum has cooled, with the 7 day and 30 day share price returns both negative. However, the 90 day gain of 12.7% and 1 year total shareholder return of 54.3% still indicate stronger performance over a longer...

Wondering whether SoftBank Group's current share price actually lines up with its underlying value? This article walks through the numbers so you can see how the market is pricing the story. The stock closed at ¥3,578 after an 8.9% decline over the last 7 days, a 24.0% drop over 30 days and a 22.5% fall year to date, while the 1 year return sits at 83.4% and the 3 year return is very large at about 3x. These swings have come as SoftBank Group continues to be closely watched as a major...

Earlier this month, Metaplanet Inc. approved the creation of a wholly owned subsidiary, Metaplanet Ventures K.K., committing about ¥4,000 million over two to three years to invest in Bitcoin financial infrastructure, incubate early-stage domestic projects, and fund Bitcoin-focused grants in Japan. This move effectively turns Metaplanet into a corporate backer of Japan’s regulated Bitcoin ecosystem, linking its Bitcoin income business directly to venture, incubator, and developer-support...

Takeda Pharmaceutical stock snapshot Takeda Pharmaceutical (TSE:4502) has drawn investor attention after a period of steady trading, with its share price around ¥5,673 and multi year total returns along with recent revenue and net income figures in focus. See our latest analysis for Takeda Pharmaceutical. At around ¥5,673 per share, Takeda Pharmaceutical has delivered a 90 day share price return of 27.54%, while its 1 year total shareholder return of 33.82% points to building momentum beyond...

In early March 2026, Arrcus announced a collaboration with Fujitsu and 1Finity to combine FUJITSU-MONAKA Arm-based CPUs, ArcOS software-defined networking, and high-speed optical interconnects into a secure, energy-efficient infrastructure for distributed AI workloads from edge inference to large-scale training. This partnership highlights Fujitsu’s push to align compute, networking, and optical transport for emerging Physical and enterprise AI use cases such as smart factories, robotics,...

Why Marubeni’s Branford Castle deal matters for shareholders Marubeni (TSE:8002) has drawn investor attention after committing capital to Branford Castle Partners’ new flagship fund and agreeing to work alongside the firm to source and support global investment opportunities. See our latest analysis for Marubeni. The Branford Castle agreement lands while Marubeni’s share price sits at ¥5,591, with a 1 day share price return of 4.02% and 7 day return of 3.86%. However, the 30 day share price...

OMRON (TSE:6645) has released its SF2030 2nd Stage medium term plan, outlining a broad shift toward data driven operations. The plan highlights increased focus on industrial automation, healthcare, and targeted growth in Europe. This roadmap sets out multi year priorities for redirecting investment and reshaping the company’s business mix. OMRON, trading at ¥4,532.0, enters this new phase after a mixed share price record, with a 13.4% return year to date and a 3.5% return over 1 year,...

Japan Steel Works recently moved to expand its production capacity to serve rising orders from the recovering global nuclear energy sector, reinforcing its role in supplying advanced components and industrial machinery. This capacity build-out highlights how Japan Steel Works is tying its engineering and manufacturing expertise more closely to long-cycle nuclear infrastructure projects worldwide. We will now examine how this nuclear-focused capacity expansion shapes Japan Steel Works’...

Furukawa Electric has announced extensive executive transfers, new duties, and board director candidates following its March 5 Board of Directors meeting, with many changes taking effect from April 1 and further transitions planned through June 26, 2026. The reshuffle concentrates leadership around key domains such as digital infrastructure components, automotive systems, and energy infrastructure, suggesting a sharpened focus on technology-driven and infrastructure-related businesses. Next,...

Why Fujikura’s latest fiber optics moves matter for shareholders Fujikura (TSE:5803) has been in focus after new agreements with US Conec, Corning and Sumitomo Electric Lightwave to extend the MMC VSFF platform using PRIZM TMT expanded beam optics for high density connectivity. See our latest analysis for Fujikura. The PRIZM TMT agreements come at a time when momentum in Fujikura’s shares has been strong, with a 30 day share price return of 15.0% and a year to date share price return of...

Toro Neurovascular previously announced that the U.S. FDA had granted 510(k) clearance for its Toro 88 Superbore Catheter, with Kaneka Medical America LLC leading the U.S. commercial launch following the device’s first successful clinical use by Dr. Satoshi Tateshima. This launch underscores Kaneka’s deeper involvement in the neurovascular device market, pairing Toro’s catheter technology with Kaneka’s established U.S. sales and clinical support network. We’ll now examine how Kaneka’s role...

On March 10, 2026, TIS Inc. (TSE:3626) announced a share repurchase program of up to 20,000,000 shares, or 8.76% of outstanding shares, for ¥50,000 million running through September 30, 2026, with any repurchased shares above 5% of issued shares to be cancelled. This buyback, framed as a way to enhance shareholder returns and capital efficiency, could meaningfully reshape TIS’s balance between growth investment and capital return. We will examine how TIS’s sizeable share repurchase plan,...

In March 2026, Frontier Lithium announced it had signed a non-binding Memorandum of Understanding with Panasonic Energy and Mitsubishi to explore lithium hydroxide procurement and broader collaboration around the PAK Lithium Project in Ontario, aimed at supplying North America’s electric vehicle battery supply chain from 2030. A key insight is that Mitsubishi’s existing joint venture role in the PAK Lithium Project now sits within a wider potential offtake and technical cooperation framework...